All Stories

  1. Cross-Database Characterization of Flavonoids and Phenolic Acids: Integrating Drug-likeness Metrics, Molecular Interactions, and Dietary Sources
  2. Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
  3. Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950–2023: a demographic analysis for the Global Burden of Disease Study 2023
  4. Vitamin D and Postoperative Recovery in Elderly Ribeirinhos—Riverside Amazon Communities with Femur Fractures
  5. Predictive modeling of depression and anxiety after myocardial infarction: a study on influential factors and heart rate variability
  6. Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage
  7. Global, regional, and national prevalence of kidney failure with replacement therapy and associated aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
  8. Photobiomodulation Therapy Reduces Oxidative Stress and Inflammation to Alleviate the Cardiotoxic Effects of Doxorubicin in Human Stem Cell-Derived Ventricular Cardiomyocytes
  9. Prevalence of Vision Loss in Latin America and the Caribbean in 2020: Magnitude and Temporal Trends
  10. Designing Personalized Multimodal Mnemonics With AI: A Medical Student’s Implementation Tutorial
  11. Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019
  12. Human Pinealectomy Syndrome and the Impact of Melatonin Replacement Therapy: 1‐Cardiovascular Function
  13. Circadian system coordination: new perspectives beyond classical models
  14. Correction: Comparison between melatonin versus melatonin and photobiomodulation versus photobiomodulation in the treatment of Alopecia X in German Spitz dogs: Clinical, randomized, double-blind, parallel, non-inferiority protocol
  15. Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
  16. Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
  17. Global, regional, and national progress towards the 2030 global nutrition targets and forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021
  18. Comparing and assessing physical activity and sedentary behaviour guidelines for different populations with and without chronic conditions and/or disabilities: a systematic review protocol
  19. High-frequency chest wall oscillation devices: An umbrella review and bibliometric analysis
  20. Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  21. Global, regional, and national burden of pulmonary arterial hypertension, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  22. From science to society: Exploring the nexus between obesity research and public awareness in Brazil
  23. Global estimates on the number of people blind or visually impaired by Uncorrected Refractive Error: a meta-analysis from 2000 to 2020
  24. Comparison between melatonin versus melatonin and photobiomodulation versus photobiomodulation in the treatment of Alopecia X in German Spitz dogs: Clinical, randomized, double-blind, parallel, non-inferiority protocol
  25. The burden of neurological conditions in north Africa and the Middle East, 1990–2019: a systematic analysis of the Global Burden of Disease Study 2019
  26. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  27. Burden of disease scenarios for 204 countries
  28. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  29. Global estimates on the number of people blind or visually impaired by glaucoma: A meta-analysis from 2000 to 2020
  30. Global Health Trends 1950–2021: Impact of COVID-19 on Mortality and Population Growth
  31. Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  32. Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
  33. Evidence for the druggability of aldosterone targets in heart failure: A bioinformatics and data science-driven decision-making approach
  34. High and low pitch sound stimuli effects on heart-brain coupling
  35. Global Burden of Cardiovascular Diseases and Risks, 1990-2022
  36. High and Low Pitch Sound Stimuli Effects on Heart-Brain Coupling
  37. Global burden of peripheral artery disease and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  38. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021
  39. Determinants of cervical spine disorders in military pilots: a systematic review
  40. The burden of metabolic risk factors in North Africa and the Middle East, 1990–2019: findings from the Global Burden of Disease Study
  41. Effect of air pollution on disease burden, mortality, and life expectancy in North Africa and the Middle East: a systematic analysis for the Global Burden of Disease Study 2019
  42. Global burden of chronic respiratory diseases and risk factors, 1990–2019: an update from the Global Burden of Disease Study 2019
  43. Sexual Dimorphism in the Expression of Cardiac and Hippocampal Renin-Angiotensin and Kallikrein–Kinin Systems in Offspring from Mice Exposed to Alcohol during Gestation
  44. Multiplatform-Integrated Identification of Melatonin Targets for a Triad of Psychosocial-Sleep/Circadian-Cardiometabolic Disorders
  45. Quantitative cardiac autonomic outcomes of hydrotherapy in women during the first stage of labor
  46. Editorial: Methods and applications in integrative physiology
  47. “Involve Me and I Learn”: Active Learning in a Hybrid Medical Biochemistry First Year Course on an American-Style MD Program in the UAE
  48. Burnout and Cardiovascular Risk in Healthcare Professionals During the COVID-19 Pandemic
  49. Photobiomodulation therapy's effects on cardiac fibrosis activation after experimental myocardial infarction
  50. Urinary Angiotensinogen-Melatonin Ratio in Gestational Diabetes and Preeclampsia
  51. Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019
  52. Heart Rate Variability Indices as Possible Biomarkers for the Severity of Post-traumatic Stress Disorder Following Pregnancy Loss
  53. The validation of oxygen uptake efficiency slope in patients with stroke
  54. Using the Gensini score to estimate severity of STEMI, NSTEMI, unstable angina, and anginal syndrome
  55. Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  56. Physicians’ Attitudes Toward Telemedicine Consultations During the COVID-19 Pandemic: Cross-sectional Study
  57. Cross-Cultural Adaptation, Reliability, and Validity of a Brazilian of Short Version of the Posttraumatic Diagnostic Scale
  58. Health and Well-Being of Athletes During the Coronavirus Pandemic: A Scoping Review
  59. Bang the gavel: animal experimentation on trial—an interdisciplinary mock trial at the school of health sciences
  60. Prevalence and Determinants of Immediate and Long-Term PTSD Consequences of Coronavirus-Related (CoV-1 and CoV-2) Pandemics among Healthcare Professionals: A Systematic Review and Meta-Analysis
  61. The action of aripiprazole and brexpiprazole at the receptor level in singultus
  62. Impact of COVID-19 Pandemic Burnout on Cardiovascular Risk in Healthcare Professionals Study Protocol: A Multicenter Exploratory Longitudinal Study
  63. The value of coronary computed tomography angiography in assessing the cardiac circulation of an outpatient-based population
  64. The efficacy of baroreflex activation therapy for heart failure
  65. Cardiovascular and Quality of Life Outcomes of a 3-Month Physical Exercise Program in Two Brazilian Communities
  66. Next-generation sequencing identifies a novel heterozygous I229T mutation on LMNA associated with familial cardiac conduction disease
  67. Cardiovascular and Quality of Life Outcomes of a 3-Month Physical Exercise Program in Two Brazilian Communities
  68. Melatonin Therapy Improves Cardiac Autonomic Modulation in Pinealectomized Patients
  69. Therapeutic Renin Inhibition in Diabetic Nephropathy—A Review of the Physiological Evidence
  70. What is the optimal duration of the TILT after administration of 0.4 mg nitroglycerin spray?
  71. Cardioprotective Melatonin: Translating from Proof-of-Concept Studies to Therapeutic Use
  72. Clinical outcomes of discordant exercise electrocardiographic and echocardiographic findings compared with concordant findings in patients with chest pain and no history of coronary artery disease
  73. Physical Activity Levels in a Structured Physical Exercise Community Program in Elderly
  74. Association between gene variants and the recurrence of atrial fibrillation
  75. Integrative bioinformatics analysis of miRNA and mRNA expression profiles and identification of associated miRNA-mRNA network in aortic dissection
  76. The Syntaxin-1A gene single nucleotide polymorphism rs4717806 associates with the risk of ischemic heart disease
  77. Obesity and metabolic syndrome in children in Brazil
  78. Identification of insulin-regulated aminopeptidase (IRAP) in the rat pineal gland and the modulation of melatonin synthesis by angiotensin IV
  79. Intrapartum Fetal Heart Rate: A Possible Predictor of Neonatal Acidemia and APGAR Score
  80. Melatonin, mitochondria and hypertension
  81. Association between Carotid Intima Media Thickness and Heart Rate Variability in Adults at Increased Cardiovascular Risk
  82. Quantifying Effects of Pharmacological Blockers of Cardiac Autonomous Control Using Variability Parameters
  83. Angiotensin—Encyclopedia of Stress
  84. Hormonal Physiology of Childbearing, an Essential Framework for Maternal–Newborn Nursing
  85. ICU Blood Pressure Variability May Predict Nadir of Respiratory Depression After Coronary Artery Bypass Surgery
  86. Morlet wavelet transforms of heart rate variability for autonomic nervous system activity
  87. Successful Pregnancy Following Assisted Reproduction in Woman With Systemic Lupus Erythematosus and Hypertension
  88. Cardiac autonomic dysfunction in elderly women with myocardial infarction
  89. PP.LB01.19
  90. Development of a monitoring system for evaluation of the mental health program in the city of Santarém, State of Pará, Brazil
  91. Sex-dependent differences in renal angiotensinogen as an early marker of diabetic nephropathy
  92. Heart Rate Detrended Fluctuation Indexes as Estimate of Obstructive Sleep Apnea Severity
  93. Avosentan is protective in hypertensive nephropathy at doses not causing fluid retention
  94. The Angiotensin-Melatonin Axis
  95. Brain RAS: Hypertension and Beyond
  96. Cardiovascular responses evoked by activation or blockade of GABAA receptors in the hypothalamic PVN are attenuated in transgenic rats with low brain angiotensinogen
  97. Differential diagnosis between experimental endophthalmitis and uveitis in vitreous with Raman spectroscopy and principal components analysis
  98. Brain Renin–Angiotensin System in Hypertension, Cardiac Hypertrophy, and Heart Failure
  99. Models of Hypertension and Blood Pressure Recording
  100. Antidiuretic Effects of the Endothelin Receptor Antagonist Avosentan
  101. Effect of SPP 635, a renin inhibitor, on intraocular pressure in glaucomatous monkey eyes
  102. Local renin–angiotensin system and the brain—A continuous quest for knowledge
  103. Effect of SPP 301, an Endothelin Antagonist, on Intraocular Pressure in Glaucomatous Monkey Eyes
  104. Nigral and striatal regulation of angiotensin receptor expression by dopamine and angiotensin in rodents: implications for progression of Parkinson’s disease
  105. Transgenic Angiotensin-Converting Enzyme 2 Overexpression in Vessels of SHRSP Rats Reduces Blood Pressure and Improves Endothelial Function
  106. Increased susceptibility to endotoxic shock in transgenic rats with endothelial overexpression of kinin B1 receptors
  107. Baroreflex control of heart rate and renal sympathetic nerve activity in rats with low brain angiotensinogen
  108. Antidiuretic effects of endothelin B receptor antagonism
  109. Mice deficient for both kinin receptors are normotensive and protected from endotoxin-induced hypotension
  110. Angiotensin*
  111. Angiotensin1
  112. Enhanced isoproterenol-induced cardiac hypertrophy in transgenic rats with low brain angiotensinogen
  113. Brain renin-angiotensin system
  114. Altered circadian rhythm reentrainment to light phase shifts in rats with low levels of brain angiotensinogen
  115. Role of the renal nerves in blood pressure in male and female SHR
  116. Altered renal response to acute volume expansion in transgenic rats harboring the human tissue kallikrein gene
  117. Genetic targeting of the brain renin-angiotensin system in transgenic rats: Impact on stress-induced renin release
  118. Differential regulation of central vasopressin receptors in transgenic rats with low brain angiotensinogen
  119. Expression of an angiotensin-(1–7)-producing fusion protein produces cardioprotective effects in rats
  120. CIRCADIAN REGULATION OF ANGIOTENSINOGEN IN KIDNEY - EFFECT OF ANGIOTENSIN II
  121. Androgen receptor independent cardiovascular action of the antiandrogen flutamide
  122. Expression of smooth muscle MyHC B in blood vessels of hypertrophied heart in experimentally hypertensive rats
  123. Brain Renin-Angiotensin System
  124. Abolition of End-Organ Damage by Antiandrogen Treatment in Female Hypertensive Transgenic Rats
  125. Abolition of Hypertension-Induced End-Organ Damage by Androgen Receptor Blockade in Transgenic Rats Harboring the Mouse Ren-2 Gene
  126. Differential effects of angiotensin II and angiotensin-(1-7) at the nucleus tractus solitarii of transgenic rats with low brain angiotensinogen
  127. Locally synthesized angiotensin modulates pineal melatonin generation
  128. Tissue renin-angiotensin systems: new insights from experimental animal models in hypertension research
  129. Alterations in Blood Pressure and Heart Rate Variability in Transgenic Rats With Low Brain Angiotensinogen
  130. Alterations of the renin-angiotensin system at the RVLM of transgenic rats with low brain angiotensinogen
  131. Reduced cardiac hypertrophy and altered blood pressure control in transgenic rats with the human tissue kallikrein gene
  132. ALTERED CARDIOVASCULAR FUNCTIONALITY OF THE RENIN-ANGIOTENSIN SYSTEM AT THE ROSTRAL VENTROLATERAL MEDULLA OF TRANSGENIC RATS WITH LOW BRAIN ANGIOTENSINOGEN
  133. Angiotensin peptides acting at rostral ventrolateral medulla contribute to hypertension of TGR(mREN2)27 rats
  134. The Brain Renin-Angiotensin System Modulates Angiotensin II-Induced Hypertension and Cardiac Hypertrophy
  135. Blood pressure reduction and diabetes insipidus in transgenic rats deficient in brain angiotensinogen
  136. Functional evidence for alternative ANG II-forming pathways in hamster cardiovascular system
  137. Local renin–angiotensin system in the pineal gland
  138. High levels of human chymase expression in the pineal and pituitary glands
  139. Mechanismus der Gewebe-Angiotensin-II-Bildung im Herzen und neue Befunde zum kardialen Angiotensin-II-System
  140. Effects of α-trinositol administered extra- and intracellularly (using liposomes) on rat aorta rings
  141. Multiple effects of tyrosine kinase inhibitors on vascular smooth muscle contraction
  142. Effects of liposome-entrapped platelet-activating factor in the isolated rat trachea